NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01286987 2019-01-10Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid TumorsPfizerPhase 1 Completed113 enrolled 39 charts
NCT00966277 2016-12-12Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsM.D. Anderson Cancer CenterPhase 4 Completed87 enrolled 9 charts
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled
NCT00294203 2014-04-15Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for CancerUniversity of FloridaPhase 1 Completed40 enrolled
NCT00060502 2011-05-17A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related CachexiaCentocor, Inc.Phase 2 Completed73 enrolled